Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 2
This trial is looking at measuring circulating tumour DNA (ctDNA) in the blood from breast cancer. Doctors may then treat the cancer by adding ipatasertib to fulvestrant and palbociclib.
The trial is for people whose cancer has:
spread into surrounding tissues or elsewhere in the body
a large number of receptors for the hormone
none or a small number of the HER2 receptors ()
Recruitment start: 28 December 2022
Recruitment end: 1 July 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alicia Okines
F.Hoffmann-La Roche Ltd (Roche)
Foundation Medicine
Pfizer Inc.
The Royal Marsden NHS Foundation Trust
Last reviewed: 1 July 2025
CRUK internal database number: 19061
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
